Optimising the management of acute malnutrition

Affiliations

¹ Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, Belgium; Pediatric Department, Université Catholique de Bukavu, 285 Bukavu, Democratic Republic of the Congo; General Pediatrics, Pediatric Department, Hôpital Provincial Général de Référence de Bukavu, Bukavu, Democratic Republic of the Congo. Electronic address: richkambale7@gmail.com.
² Pediatric Department, Université Catholique de Bukavu, 285 Bukavu, Democratic Republic of the Congo; General Pediatrics, Pediatric Department, Hôpital Provincial Général de Référence de Bukavu, Bukavu, Democratic Republic of the Congo.

Free article

Comment

Richard Mbusa Kambale et al. Lancet Glob Health. 2022 Apr.

Free article

. 2022 Apr;10(4):e453-e454.

doi: 10.1016/S2214-109X(22)00087-0.

¹ Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, Belgium; Pediatric Department, Université Catholique de Bukavu, 285 Bukavu, Democratic Republic of the Congo; General Pediatrics, Pediatric Department, Hôpital Provincial Général de Référence de Bukavu, Bukavu, Democratic Republic of the Congo. Electronic address: richkambale7@gmail.com.
² Pediatric Department, Université Catholique de Bukavu, 285 Bukavu, Democratic Republic of the Congo; General Pediatrics, Pediatric Department, Hôpital Provincial Général de Référence de Bukavu, Bukavu, Democratic Republic of the Congo.

No abstract available

Conflict of interest statement

We declare no competing interests.

Simplifying and optimising the management of uncomplicated acute malnutrition in children aged 6-59 months in the Democratic Republic of the Congo (OptiMA-DRC): a non-inferiority, randomised controlled trial.
Cazes C, Phelan K, Hubert V, Boubacar H, Bozama LI, Sakubu GT, Tshiala BK, Tusuku T, Alitanou R, Kouamé A, Yao C, Gabillard D, Kinda M, Daures M, Augier A, Anglaret X, Shepherd S, Becquet R. Cazes C, et al. Lancet Glob Health. 2022 Apr;10(4):e510-e520. doi: 10.1016/S2214-109X(22)00041-9. Lancet Glob Health. 2022. PMID: 35303461 Clinical Trial.